Results 91 to 100 of about 139,220 (339)

Arterial hypertension in kidney transplant recipients: pathophysiology, diagnostics, treatment

open access: yesВестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
Relevance: Arterial hypertension (HTN) in kidney transplant recipients is a major risk factor for cardiovascular diseases, graft rejection and premature death.
M. Sh. Khubutiya   +5 more
doaj   +1 more source

Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national blood pressure study cohort [PDF]

open access: yes, 2002
Objectives: To identify simple long term predictors of maintenance of normotension after withdrawal of antihypertensive drugs in elderly patients in general practice. Design: Prospective cohort study. Setting: 169 general practices in Victoria, Australia.
Krum, H.   +5 more
core   +2 more sources

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou   +7 more
wiley   +1 more source

Adherence to Antihypertensives in Patients With Comorbid Condition. [PDF]

open access: yes, 2015
BackgroundComorbidity has been noted as a potential barrier to proper adherence to antihypertensive medications.ObjectivesWe decided to investigate whether comorbidity could significantly affect adherence of Iranian patients with hypertension to their ...
Aerab-Sheibani, Hossein   +7 more
core   +1 more source

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 888-899, April 2025.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki   +11 more
wiley   +1 more source

Hypertension - state of the art 2017 [PDF]

open access: yes, 2017
No abstract ...
McCallum, Linsay
core   +1 more source

Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1283-1294, April 2025.
Abstract Aims We aim to describe the incidence of HF hospitalization in France in the post‐pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio‐economic differences and to analyse time‐trends between 2012 and 2022.
Valérie Olié   +5 more
wiley   +1 more source

Resistant/Refractory Hypertension and Sleep Apnoea: Current Knowledge and Future Challenges [PDF]

open access: yes, 2019
Hypertension is one of the most frequent cardiovascular risk factors. The population of hypertensive patients includes some phenotypes whose blood pressure levels are particularly difficult to control, thus putting them at greater cardiovascular risk ...
Barbé Illa, Ferran   +7 more
core   +2 more sources

Survival after myocardial infarction according to left ventricular function and heart failure symptoms

open access: yesESC Heart Failure, EarlyView.
Asymptomatic reduced left ventricular ejection fraction (LVEF) in the acute phase of myocardial infarction (AMI) was associated with up to 20% 1‐year mortality after discharge, substantially higher than in recent post‐MI trials. Symptoms of heart failure (HF) during the index hospitalization was associated with worse outcomes in patients with preserved
Jarle Jortveit   +3 more
wiley   +1 more source

Motivational Interviewing Impact on Cardiovascular Disease [PDF]

open access: yes, 2020
: Harm reduction in cardiovascular disease is a significant problem worldwide. Providers, families, and healthcare agencies are feeling the burdens imparted by these diseases.

core  

Home - About - Disclaimer - Privacy